Florastor significantly reduces the risk of antibiotic-associated diarrhea (AAD) in adults
The incidence of diarrhea in patients receiving Florastor (250 mg bid) was significantly lower (N=1/73, 1.4%) vs. placebo (n=7/78, 9%; p<0.05)11.
Florastor significantly reduces the risk of antibiotic-associated diarrhea (AAD) in children
Florastor (250 mg bid) reduced the risk of antibiotic-associated diarrhea vs. antibiotics alone by 78% (n=6/139, 4% vs. n=28/144, 19% CI: 0.09-0.55)5.